Enbridge Inc vs Koninklijke Philips NV — how do they compare? Enbridge Inc trades at $46.54 (market cap $103.38B), while Koninklijke Philips NV trades at $24.38 (market cap $23.52B). The key difference: Enbridge Inc is far larger — about 4.4× Koninklijke Philips NV's market cap, and Enbridge Inc pays the higher dividend (6.02%). Which is the better fit depends on your goals — on Pluang, investors hold Enbridge Inc for 91 Days and Koninklijke Philips NV for 84 Days on average.
| ENB | PHG | |
|---|---|---|
Market Cap | $103.38B | $23.52B |
Volume | 3,684,305 | 1,635,069 |
Sector | Energy | Health |
52-Week High | $58.04 | $32.91 |
52-Week Low | $45.23 | $23.81 |
Typical Hold Time | 91 Days | 84 Days |
Enterprise Value | $185.39B | $29.87B |
Dividend Yield | 6.02% | 4.17% |
Signals from Pluang's Aura AI — not financial advice
Enbridge (ENB) trades at $45.89, down 1.4% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $0.46, beating expectations by 7%, and maintains a 6% dividend yield. Revenue grew to $65.19B in 2025 with net income of $7.49B, though 2026 projections show margin compression. Analyst consensus is mixed with 48% buy ratings and a $61.63 price target suggesting 34% upside potential.
ENB presents a value opportunity with discounted valuation metrics (P/E 25.27, P/S 1.72) and stable cash flows, but faces headwinds from rising interest rates and energy market volatility. The stock's current technical weakness contrasts with fundamental strength, creating potential for recovery if operational execution continues to outperform expectations.
PHG trades at $24.09, down 0.25% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Recent news highlights product innovations including new CT systems and AI healthcare tools, while institutional investors like Bank of America and Arrowstreet Capital have increased positions.
PHG presents a mixed outlook with solid profitability recovery but technical weakness. The stock offers value at reasonable valuations (P/E 18.84, P/S 1.18) and analyst consensus leans Hold (63.64%). Key risks include cybersecurity threats (Reuters, 2026-08-13) and debt levels, while opportunities lie in healthcare technology expansion and Exor's potential increased stake to 22% (Reuters, 2026-08-11).
Trailing returns across standard periods
Latest headlines on both assets
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →